journal article Feb 01, 2013

A study on the association of TNF-α-308, IL-6-174, IL-10-1082 and IL-1RaVNTR gene polymorphisms with rheumatic heart disease in Pakistani patients

Cytokine Vol. 61 No. 2 pp. 527-531 · Elsevier BV
View at Publisher Save 10.1016/j.cyto.2012.10.020
Topics

No keywords indexed for this article. Browse by subject →

References
41
[1]
Sadiq "Prevalence of rheumatic heart disease in school children of urban Lahore" Heart (2009) 10.1136/hrt.2008.143982
[2]
Rizvi "Status of rheumatic heart disease in rural Pakistan" Heart (2004) 10.1136/hrt.2003.025981
[3]
Rheumatic Fever and Rheumatic Heart Disease: Genetics and Pathogenesis

L. Guilherme, R. Ramasawmy, J. Kalil

Scandinavian Journal of Immunology 2007 10.1111/j.1365-3083.2007.01974.x
[4]
Guilherme "Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease" J Clin Immunol (2010) 10.1007/s10875-009-9332-6
[5]
Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation

Anthony G. Wilson, Julian A. Symons, Tarra L. McDowell et al.

Proceedings of the National Academy of Sciences 1997 10.1073/pnas.94.7.3195
[6]
Elahi "Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease" Biochim Biophys Acta (2009) 10.1016/j.bbadis.2009.01.007
[7]
Miller "Cytokines and immunoglobulin in rheumatic heart disease: production by blood and tonsillar mononuclear cells" J Rheumatol (1989)
[8]
Guilherme "Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions" Am J Pathol (2004) 10.1016/s0002-9440(10)63415-3
[9]
Humphries "The Interleukin-6 – 174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men" Eur Heart J (2001) 10.1053/euhj.2001.2678
[10]
Maitra "Polymorphisms in the IL6 gene in Asian Indian families with premature coronary artery disease – the Indian Atherosclerosis research study" Thromb. Haemost. (2008) 10.1160/th07-11-0686
[11]
The interleukin-6 –174 G/C promoter polymorphism and arterial stiffness; the Rotterdam Study

Jacqueline Witteman

Vascular Health and Risk Management 2008 10.2147/vhrm.s1693
[12]
Tonet "Association between– 174 G/C promoter polymorphism of the Interleukin-6 gene and cardiovascular disease risk factors in Brazilian older women" Braz J Med Biol Res (2008) 10.1590/s0100-879x2006005000190
[13]
[14]
Fishman "The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis" J Clin Invest (1998) 10.1172/jci2629
[15]
Turner "An investigation of polymorphism in the interleukin-10 gene promoter" Eur J Immunogenet (1997) 10.1111/j.1365-2370.1997.tb00001.x
[16]
Cavet "Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants" Blood (1999) 10.1182/blood.v94.11.3941
[17]
Lee "Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis" Mol Biol Rep (2012) 10.1007/s11033-011-0712-7
[18]
Wang "Association between the Interleukin 10–1082 G > A polymorphism and coronary heart disease risk in a Caucasian population: a meta-analysis" Int J Immunogenet (2012) 10.1111/j.1744-313x.2011.01072.x
[19]
Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat

JoannaK. Tarlow, AlexandraI.F. Blakemore, Andrew Lennard et al.

Human Genetics 1993 10.1007/bf00217368
[20]
Vamvakopoulos "The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism" Eur J Immunogenet (2002) 10.1046/j.1365-2370.2002.00319.x
[21]
Witkin "Influence of Interleukin-1 receptor antagonist gene polymorphism on disease" Clin Infect Dis (2002) 10.1086/338261
[22]
Braunwald (2001)
[23]
Sambrook (2001)
[24]
L. Excoffier, G. Laval, S. Schneider, Arlequin ver. 3.0: an integrated software package for population genetics data analysis, Evolutionary Bioinformatics Online 1 (2005) 47-50. <http://cmpg.unibe.ch/software/arlequin3>.
[25]
J. C. Pezzullo, <http://statpages.org/ctab2x2.html>, (accessed 22/05/2010).
[26]
The global burden of group A streptococcal diseases

Jonathan R Carapetis, Andrew C Steer, E Kim Mulholland et al.

The Lancet Infectious Diseases 2005 10.1016/s1473-3099(05)70267-x
[27]
Steer "Prevention and treatment of rheumatic heart disease in the developing world" Nat Rev Cardiol (2009) 10.1038/nrcardio.2009.162
[28]
Bittles "Population stratification and genetic association studies in South Asia" J Mol Genet Med (2005) 10.4172/1747-0862.1000012
[29]
Hernández-Pacheco "Tumor necrosis factor alpha promoter polymorphisms in Mexican patients with rheumatic heart disease" J. Autoimmun. (2003) 10.1016/s0896-8411(03)00079-9
[30]
Sallakci "TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production" J Autoimmun (2005) 10.1016/j.jaut.2005.05.005
[31]
Ramasawmy "Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever" Mol Immunol (2007) 10.1016/j.molimm.2006.10.001
[32]
Mekinian "Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis" Eur Cytokine Netw (2011) 10.1684/ecn.2011.0285
[33]
Pociot "Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus" Eur J Immunol (1993) 10.1002/eji.1830230135
[34]
Rehman "Human leukocyte antigen (HLA) class II association with rheumatic heart disease in Pakistan" J Heart Valve Dis (2007)
[35]
Imanishi "Estimation of allele and haplotype frequencies for HLA and complement loci" (1992)
[36]
Nauck "The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction" J Mol Med (2002) 10.1007/s00109-002-0354-2
[37]
Col-Araz "Role of cytokine gene (IFN-γ, TNF-α, TGF-β1, IL-6 and IL-10) polymorphisms in pathogenesis of acute rheumatic fever in Turkish children" Eur J Pediatr (2012) 10.1007/s00431-012-1689-5
[38]
Chou "Lack of association of genetic polymorphisms in the interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 genes with risk of rheumatic heart disease in Taiwan Chinese" Int Heart J (2005) 10.1536/ihj.46.397
[39]
Bid "Study of interleukin-1 receptor antagonist (IL-Ra) gene polymorphism in healthy individuals from Northern India" Indian J Clin Biochem (2004) 10.1007/bf02894269
[40]
Polymorphisms of IL-1B, IL-1RN, IL-2, IL-4, IL-6, IL-10, and IFN-γ genes in the Korean population

Chul-Woo Pyo, Seong-Suk Hur, Yang-Kyum Kim et al.

Human Immunology 2003 10.1016/s0198-8859(03)00173-3
[41]
Azevedo "Interleukin-1 receptor antagonist gene (IL1RN) polymorphism possibly associated to severity of rheumatic carditis in a Brazilian cohort" Cytokine (2010) 10.1016/j.cyto.2009.09.003
Metrics
31
Citations
41
References
Details
Published
Feb 01, 2013
Vol/Issue
61(2)
Pages
527-531
License
View
Cite This Article
Sadia Rehman, Naveed Akhtar, Nusrat Saba, et al. (2013). A study on the association of TNF-α-308, IL-6-174, IL-10-1082 and IL-1RaVNTR gene polymorphisms with rheumatic heart disease in Pakistani patients. Cytokine, 61(2), 527-531. https://doi.org/10.1016/j.cyto.2012.10.020
Related

You May Also Like

LPS/TLR4 signal transduction pathway

Yong-Chen Lu, Wen-Chen Yeh · 2008

2,746 citations

Interleukin-8: An evolving chemokine

Kouji Matsushima, De Yang · 2022

439 citations

TNF activity and T cells

Amit K. Mehta, Donald T. Gracias · 2018

365 citations